Clinical Research Directory
Browse clinical research sites, groups, and studies.
Placental Transfer of Sugammadex in the Human Placental Perfusion Model
Sponsor: Universitaire Ziekenhuizen KU Leuven
Summary
Preclinical research raised concern regarding the foetal effects of using sugammadex during pregnancy. However, to the best of our knowledge, the placental transfer of sugammadex has never been measured. As these data would be critical in assessing the foetal effects after maternal administration of sugammadex, it is warranted to measure the placental transfer of sugammadex. The aim of this project is to measure the placental transfer of sugammadex in the human placenta by using the ex vivo human placenta perfusion model.
Key Details
Gender
FEMALE
Age Range
18 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
16
Start Date
2025-03-17
Completion Date
2026-09
Last Updated
2026-01-09
Healthy Volunteers
No
Conditions
Interventions
Sugammadex
In an ex-vivo placenta perfusion study, placental transfer of sugammadex is measured.
Locations (1)
UZ Leuven
Leuven, Vlaams-Brabant, Belgium